Clinical trial Recruiting at 1 site Observational Ages 18 to 55

Understanding why OCD therapy fails

Official title: Cognitive and Neural Networks in Psychiatry (CNNP): Neural Mechanisms of Obsessive-compulsive Disorder (OCD) Treatment Failure (ERP in Silico)

Run by University College, London · NCT05520398 · Data updated 2026-11-12

This study is trying to understand why therapy sometimes doesn't work for people with OCD by looking at their brain activity and behavior before and after treatment.

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexAll
Enrollment90 (estimated)
SponsorUniversity College, London
Academic / other
Locations1 site (London)
StatusRecruiting
StartedNovember 10, 2021
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedDecember 19, 2024
Trial IDNCT05520398 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with obsessive-compulsive disorder who are fluent in English and are about to start therapy.

Probably not a fit

Patients with co-occurring conditions such as autism spectrum disorder, psychosis, or severe learning disabilities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the neural mechanisms that contribute to treatment failure in patients with obsessive-compulsive disorder (OCD). It will assess patients before and after undergoing cognitive behavioral therapy (CBT) with exposure and response prevention (ERP), focusing on symptom severity and decision-making processes. By evaluating changes in behavior and symptom alleviation, the study seeks to enhance therapy outcomes for OCD patients. A total of 90 participants will be recruited at University College London's Wellcome Centre for Human Neuroimaging.

Why it matters

Potential benefit: If successful, this study could lead to improved therapeutic strategies for patients with OCD, enhancing their treatment outcomes.

How similar studies have gone: While this study explores a specific aspect of OCD treatment, similar studies have shown promise in understanding therapy outcomes, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of obsessive-compulsive disorder (OCD)
* Fluent in written and spoken English
* Normal/corrected to normal vision
* Expecting to start OCD therapy

Exclusion Criteria:

* Autism spectrum disorder, psychosis, schizophrenia, addiction, substance abuse, bipolar, hoarding, or Tourette disorder
* Hearing conditions: tinnitus, ear inflammation, hearing sensitivity, hearing loss, requires hearing aids
* Colour blindness
* Severe learning disabilities

Where it's running

  • Max Planck UCL Centre for Computational Psychiatry and Ageing Research
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.